Thousand Oaks Biopharmaceuticals provides a full range of services from cell culture media, process development to contract manufacturing of preventative biologics - veterinary/human vaccine products.
"JSBiosciences", the cell culture media brand under Thousand Oaks Biopharmaceuticals, provides a variety of media products for vaccine manufacturers, including chemical definition, serum-free, and low serum cell culture media. It also provides comprehensive services for vaccine manufacturers in the fields from cell to process, including:
The CDMO division of Thousand Oaks Biopharmaceuticals provides complete CMC services for vaccine manufacturers. In July 2020, Thousand Oaks Biopharmaceuticals undertook the first customized vaccine production in China, and successfully developed an efficient perfusion process within 2 months. Compared with the imported cell culture media and batch cell culture media process, this has significantly improved the virus content and cell yield of unit area and also brought more value for customers.